Ahmed El-Balat

Years Active: 2018-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Jacobus Pfisterer, Florence Joly Lobbedez, Gunnar B Kristensen, Joern Rau, Sven Mahner, Patricia Pautier, Ahmed El-Balat, Jean-Emmanuel Kurtz, Ulrich Canzler, Jalid Sehouli, Martin L Heubner, Andreas D Hartkopf, Klaus Baumann, Annette Hasenburg, Lars C Hanker, Antje Belau, Barbara Schmalfeldt, Dominik Denschlag, Tjoung-Won Park-Simon, Frédéric Selle, Christian Jackisch, Alexander Burges, Hans-Joachim Lück, Günter Emons, Werner Meier, Martina Gropp-Meier, Willibald Schröder, Nikolaus de Gregorio, Felix Hilpert, Philipp Harter
Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Ahmed El-Balat, Thomas Karn, Uwe Holtrich, Sven Becker, Stefan Kommoss, Balázs Győrffy, Michael S Anglesio, David G Huntsman, Zacharias Drosos, Achim Rody, Heidrun Gevensleben, Lars C Hanker
Histotype-specific analysis of acid ceramidase expression in ovarian cancer. Virchows Archiv : an international journal of pathology 476 (6) (2020)
Ahmed El-Balat, Iryna Schmeil, Khayal Gasimli, Nicole Sänger, Thomas Karn, Andre Ahr, Sven Becker, Ruza Arsenic, Uwe Holtrich, Knut Engels
Claudin-1 is linked to presence of implants and micropapillary pattern in serous borderline epithelial tumours of the ovary. Journal of clinical pathology 71 (12) (2018)

Ahmed El-Balat.css-eqlu8i{font-size:small;padding-left:4px;}